Hepatitis B virus-encoded X protein downregulates EGFR expression via inducing microRNA-7 in hepatocellular carcinoma cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Yun Ju ^a,b   Chien, Pei Hsuan ^b   Chen, Wen Shu ^c,d   Chien, Yu Fong ^a   Hsu, Ya Ying ^a   Wang, Li Yun ^c   Chen, Jhen Yu ^d   Lin, Chih Wen ^a,b   Huang, Tzung Chi ^d   Yu, Yung Luen ^c,d,e   Huang, Wei Chien ^c,d,e  

^a I SHOU UNIVERSITY   (Taiwan)

^b E DA HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 7; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; GROWTH RATE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION;

EID: 84880176260     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/682380     Document Type: Article

References (65)

1. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and Molecular Carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061 (Pubitemid 46890874)
2. Llovet J. M., Burroughs A., Bruix J., Hepatocellular carcinoma. Lancet 2003 362 9399 1907 1917 2-s2.0-0141491273 10.1016/S0140-6736(03)14964-1 (Pubitemid 37518510)
3. Fung J., Lai C.-L., Yuen M.-F., Hepatitis B and C virus-related carcinogenesis. Clinical Microbiology and Infection 2009 15 11 964 970 2-s2.0-70449134824 10.1111/j.1469-0691.2009.03035.x
4. Parkin D. M., Bray F. I., Devesa S. S., Cancer burden in the year 2000. The global picture. European Journal of Cancer 2001 37 supplement 8 S4 S66 2-s2.0-0034767957
5. Bouchard M. J., Navas-Martin S., Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Letters 2011 305 2 123 143 2-s2.0-79955482701 10.1016/j.canlet.2010.11.014
6. Berasain C., Castillo J., Perugorria M. J., Latasa M. U., Prieto J., Avila M. A., Inflammation and liver cancer: new molecular links. Annals of the New York Academy of Sciences 2009 1155 206 221 2-s2.0-61649106928 10.1111/j.1749-6632.2009.03704.x
7. Friedman S. L., Mechanisms of hepatic fibrogenesis. Gastroenterology 2008 134 6 1655 1669 2-s2.0-42949163491 10.1053/j.gastro.2008.03.003 (Pubitemid 351615417)
8. Roberts L. R., Gores G. J., Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Seminars in Liver Disease 2005 25 2 212 225 2-s2.0-20344366296 10.1055/s-2005-871200 (Pubitemid 40781073)
9. Bouchard M. J., Schneider R. J., The enigmatic X gene of hepatitis B virus. Journal of Virology 2004 78 23 12725 12734 2-s2.0-8644274040 10.1128/JVI.78.23.12725-12734.2004 (Pubitemid 39507781)
10. Seeger C., Mason W. S., Hepatitis B virus biology. Microbiology and Molecular Biology Reviews 2000 64 1 51 68 (Pubitemid 30143840)
11. Kim C.-M., Koike K., Saito I., Miyamura T., Jay G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991 351 6324 317 320 2-s2.0-0025907983 10.1038/351317a0 (Pubitemid 21896589)
12. Yu D.-Y., Moon H.-B., Son J.-K., Jeong S., Yu S.-L., Yoon H., Han Y.-M., Lee C.-S., Park J.-S., Lee C.-H., Hyun B.-H., Murakami S., Lee K.-K., Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. Journal of Hepatology 1999 31 1 123 132 2-s2.0-0033058294 10.1016/S0168-8278(99)80172-X (Pubitemid 29287618)
13. Bouchard M., Giannakopoulos S., Wang E. H., Tanese N., Schneider R. J., Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. Journal of Virology 2001 75 9 4247 4257 2-s2.0-0035048023 10.1128/JVI.75.9.4247-4257.2001 (Pubitemid 32410137)
14. Lee S., Tarn C., Wang W.-H., Chen S., Hullinger R. L., Andrisani O. M., Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming Versus nontransforming hepatocyte (AML12) cell lines. Journal of Biological Chemistry 2002 277 10 8730 8740 2-s2.0-0037040927 10.1074/jbc.M108025200 (Pubitemid 34968341)
15. Pan J., Duan L.-X., Sun B. S., Feitelson M. A., Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF- B. Journal of General Virology 2001 82 1 171 182 2-s2.0-0035155733 (Pubitemid 32045807)
16. Slagle B. L., Lee T. H., Medina D., Finegold M. J., Butel J. S., Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Molecular Carcinogenesis 1996 15 4 261 269 (Pubitemid 26146864)
17. Terradillos O., Billet O., Renard C.-A., Levy R., Molina T., Briand P., Buendia M. A., The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997 14 4 395 404 2-s2.0-0031035764 (Pubitemid 27087102)
18. Yu D.-H., Lin J., Qu J.-H., Zhu Z., Li F.-M., Ni C.-R., Zhu M.-H., Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways. Nan Fang Yi Ke Da Xue Xue Bao 2009 29 6 1089 1093 2-s2.0-77952783891
19. Sirma H., Giannini C., Poussin K., Paterlini P., Kremsdorf D., Bréchot C., Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999 18 34 4848 4859 2-s2.0-0033607041 10.1038/sj.onc.1202867 (Pubitemid 29423568)
20. Lu H.-M., Cheng P., Tang Q.-Q., Chen P., Peng X.-C., Li Y.-H., Wen Y.-J., Wei Y.-Q., Inhibition of tumour cells with hepatitis B virus x (HBx) gene adenoviral vector in vivo. Sichuan Da Xue Xue Bao Yi Xue Ban 2009 40 5 803 806 2-s2.0-70349730125
21. Kuo C.-Y., Wu C.-C., Hsu S.-L., Hwang G.-Y., HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3 β / β -catenin cascade. Intervirology 2008 51 2 130 136 2-s2.0-47549097753 10.1159/000139131 (Pubitemid 352009472)
22. Shirakata Y., Koike K., Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. Journal of Biological Chemistry 2003 278 24 22071 22078 2-s2.0-0038158319 10.1074/jbc.M301606200 (Pubitemid 36792617)
23. Kim K.-H., Seong B. L., Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO Journal 2003 22 9 2104 2116 2-s2.0-0038558163 10.1093/emboj/cdg210 (Pubitemid 36565535)
24. Breuhahn K., Longerich T., Schirmacher P., Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 2006 25 27 3787 3800 2-s2.0-33745552897 10.1038/sj.onc.1209556 (Pubitemid 43980474)
25. Berasain C., Perugorria M. J., Latasa M. U., Castillo J., Goñi S., Santamaría M., Prieto J., Avila M. A., The epidermal growth factor receptor: a link between inflammation and liver cancer. Experimental Biology and Medicine 2009 234 7 713 725 2-s2.0-67650227488 10.3181/0901-MR-12
26. Kira S., Nakanishi T., Suemori S., Kitamoto M., Watanabe Y., Kajiyama G., Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver 1997 17 4 177 182 2-s2.0-0030825110 (Pubitemid 27394085)
27. Daveau M., Scotte M., François A., Coulouarn C., Ros G., Tallet Y., Hiron M., Hellot M.-F., Salier J.-P., Hepatocyte growth factor, transforming growth factor and their receptors as combined markers of prognosis in hepatocellular carcinoma. Molecular Carcinogenesis 2003 36 3 130 141 2-s2.0-0037335527 10.1002/mc.10103 (Pubitemid 36314790)
28. Ito Y., Takeda T., Sakon M., Tsujimoto M., Higashiyama S., Noda K., Miyoshi E., Monden M., Matsuura N., Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. British Journal of Cancer 2001 84 10 1377 1383 2-s2.0-0035906821 10.1054/bjoc.2000.1580 (Pubitemid 32522107)
29. Kong G., Zhang J., Zhang S., Shan C., Ye L., Zhang X., Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011 6 5 2-s2.0-79955870017 10.1371/journal.pone.0019518 e19518
30. Chung T.-W., Lee Y.-C., Ko J.-H., Kim C.-H., Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Research 2003 63 13 3453 3458 2-s2.0-0038418494 (Pubitemid 36793019)
31. Dewantoro O., Gani R. A., Akbar N., Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53. Acta Medica Indonesiana 2006 38 3 154 159 2-s2.0-33947515214
32. Cougot D., Neuveut C., Buendia M. A., HBV-induced carcinogenesis. Journal of Clinical Virology 2005 34 1 S75 S78 2-s2.0-32044451776 10.1016/S1386- 6532(05)80014-9 (Pubitemid 43197752)
33. Lee Y., Park U.-S., Choi I., Yoon S. K., Park Y. M., Lee Y. I., Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clinical Cancer Research 1998 4 7 1711 1717 2-s2.0-0031746396 (Pubitemid 28304733)
34. Waterman H., Yarden Y., Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Letters 2001 490 3 142 152 2-s2.0-0035895664 10.1016/S0014-5793(01)02117-2 (Pubitemid 32171933)
35. Thien C. B. F., Walker F., Langdon W. Y., RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Molecular Cell 2001 7 2 355 365 2-s2.0-0035106341 10.1016/S1097-2765(01)00183-6 (Pubitemid 32206503)
36. Ettenberg S. A., Magnifico A., Cuello M., Nau M. M., Rubinstein Y. R., Yarden Y., Weissman A. M., Lipkowitz S., Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. Journal of Biological Chemistry 2001 276 29 27677 27684 2-s2.0-0035920225 10.1074/jbc.M102641200
37. Longva K. E., Blystad F. D., Stang E., Larsen A. M., Johannessen L. E., Madshus I. H., Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. Journal of Cell Biology 2002 156 5 843 854 2-s2.0-0037018146 10.1083/jcb.200106056 (Pubitemid 34839867)
38. Sun W., Julie Li Y.-S., Huang H.-D., Shyy J. Y.-J., Chien S., MicroRNA: a master regulator of cellular processes for bioengineering systems. Annual Review of Biomedical Engineering 2010 12 1 27 2-s2.0-77955593347 10.1146/annurev-bioeng-070909-105314
39. Wang Y., Lu Y., Toh S. T., Sung W.-K., Tan P., Chow P., Chung A. Y. F., Jooi L. L. P., Lee C. G. L., Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. Journal of Hepatology 2010 53 1 57 66 2-s2.0-77953574309 10.1016/j.jhep.2009.12. 043
40. Webster R. J., Giles K. M., Price K. J., Zhang P. M., Mattick J. S., Leedman P. J., Regulation of epidermal growth factor receptor signaling in human cancer cells by MicroRNA-7. Journal of Biological Chemistry 2009 284 9 5731 5741 2-s2.0-65549120766 10.1074/jbc.M804280200
41. Li X., Carthew R. W., A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 2005 123 7 1267 1277 2-s2.0-29244437868 10.1016/j.cell.2005.10.040 (Pubitemid 41821784)
42. Giles K. M., Barker A., Zhang P. M., Epis M. R., Leedman P. J., MicroRNA regulation of growth factor receptor signaling in human cancer cells. Methods in Molecular Biology 2011 676 147 163 2-s2.0-79952202261
43. Kefas B., Godlewski J., Comeau L., Li Y., Abounader R., Hawkinson M., Lee J., Fine H., Chiocca E. A., Lawler S., Purow B., microRNA-7 inhibits the epidermal growth factor receptor and the akt pathway and is down-regulated in glioblastoma. Cancer Research 2008 68 10 3566 3572 2-s2.0-45549089973 10.1158/0008-5472.CAN-07-6639
44. Fang Y., Xue J. L., Shen Q., Chen J., Tian L., MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012 55 6 1852 1862
45. Cheng P., Li Y., Yang L., Wen Y., Shi W., Mao Y., Chen P., Lv H., Tang Q., Wei Y., Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase. Oncology Reports 2009 22 5 1101 1107 2-s2.0-70449394392 10.3892/or-00000542
46. Ning-Fang M., Lau S. H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.-C., Fung J., Bai X., Tzang C.-H., Fu L., Yang M., Su Y. A., Guan X.-Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clinical Cancer Research 2008 14 16 5061 5068 2-s2.0-52649139395 10.1158/1078-0432.CCR-07-5082
47. Endoh T., Sato D., Wada Y., Shibukawa Y., Ishihara K., Hashimoto S., Yoshinari M., Matsuzaka K., Tazaki M., Inoue T., Galanin inhibits calcium channels via G i-protein mediated by GalR1 in rat nucleus tractus solitarius. Brain Research 2008 1229 37 46 2-s2.0-49849090188 10.1016/j.brainres.2008.06.036
48. Madden C. R., Slagle B. L., Stimulation of cellular proliferation by hepatitis B virus X protein. Disease Markers 2001 17 3 153 157 2-s2.0-0035659925 (Pubitemid 34014692)
49. Kew M. C., Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2011 26 1 144 152 2-s2.0-78650769017 10.1111/j.1440-1746.2010.06546.x
50. Murakami S., Hepatitis B virus X protein: a multifunctional viral regulator. Journal of Gastroenterology 2001 36 10 651 660 2-s2.0-0034753082 10.1007/s005350170027 (Pubitemid 33040937)
51. Poussin K., Dienes H., Sirma H., Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. International Journal of Cancer 1999 80 4 497 505 (Pubitemid 29047511)
52. Wang Y., Lau S. H., Sham J. S.-T., Wu M.-C., Wang T., Guan X.-Y., Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene 2004 23 1 142 148 2-s2.0-0942289920 10.1038/sj.onc.1206889 (Pubitemid 38142248)
53. Liu L., Li Y., Zhang S., Yu D., Zhu M., Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells. Oncology Reports 2012 27 1 168 173 2-s2.0-84855296445 10.3892/or.2011.1478
54. Fu X., Tan D., Hou Z., Hu Z., Liu G., Ouyang Y., Liu F., The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation. PLoS One 2012 7 8 e43204
55. Lee J.-H., Han K.-H., Lee J. M., Park J. H., Kim H.-S., Impact of hepatitis B virus (HBV) X gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clinical and Vaccine Immunology 2011 18 6 914 921 2-s2.0-79957997336 10.1128/CVI.00474-10
56. Santarpia L., Nicoloso M., Calin G. A., MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocrine-Related Cancer 2010 17 1 F51 F75 2-s2.0-77449152336 10.1677/ERC-09-0222
57. Braconi C., Henry J. C., Kogure T., Schmittgen T., Patel T., The role of microRNAs in human liver cancers. Seminars in Oncology 2011 38 6 752 763 2-s2.0-81155138127 10.1053/j.seminoncol.2011.08.001
58. Wei X., Xiang T., Ren G., Tan C., Liu R., Xu X., Wu Z., miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cellular Signalling 2012 25 2 439 446 10.1016/j.cellsig.2012.10.013
59. Xie Q. H., He X. X., Chang Y., Jiang X., Lin J. S., HBx gene down-regulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2 Zhonghua Gan Zang Bing Za Zhi 2011 19 11 857 860
60. Wu G., Yu F., Xiao Z., Xu K., Xu J., Tang W., Wang J., Song E., Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. British Journal of Cancer 2011 105 1 146 153 2-s2.0-79959702659 10.1038/bjc.2011.190
61. Xiong S., Zheng Y., Jiang P., Liu R., Liu X., Chu Y., MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. International Journal of Biological Sciences 2011 7 6 805 814 2-s2.0-79960983743
62. Xu L., Wen Z., Zhou Y., Liu Z., Li Q., Fei G., Luo J., Ren T., MicroRNA-7 regulated TLR9 signaling enhanced growth and metastatic potential of human lung cancer cells by altering PIK3R3/Akt pathway. Molecular Biology of the Cell 2012 24 1 42 55 10.1091/mbc.E12-07-0519
63. Saydam O., Senol O., Würdinger T., Mizrak A., Ozdener G. B., Stemmer-Rachamimov A. O., Yi M., Stephens R. M., Krichevsky A. M., Saydam N., Brenner G. J., Breakefield X. O., miRNA-7 attenuation in schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Research 2011 71 3 852 861 2-s2.0-79551527320 10.1158/0008-5472.CAN-10-1219
64. Chou Y.-T., Lin H.-H., Lien Y.-C., Wang Y.-H., Hong C.-F., Kao Y.-R., Lin S.-C., Chang Y.-C., Lin S.-Y., Chen S.-J., Chen H.-C., Yeh S.-D., Wu C.-W., EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Research 2010 70 21 8822 8831 2-s2.0-78449268612 10.1158/0008-5472.CAN-10-0638
65. Khoshnan A., Patterson P. H., Elevated IKKalpha accelerates the differentiation of human neuronal progenitor cells and induces MeCP2-dependent BDNF expression. PLoS One 2012 7 7 e41794